Enteroglucagon

Annual Review of Physiology

Volumn 59, Issue , 1997, Pages 257-271

  Holst, J J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

glicentin; GLP 1; GLP 2; glucagon like peptide 1; oxyntomodulin

Indexed keywords

GLICENTIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCOSE; OXYNTOMODULIN; PROGLUCAGON;

ENDOCRINE CELL; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SECRETION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW;

ANIMALS; GLICENTIN; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; INTESTINES; OXYNTOMODULIN; PEPTIDE FRAGMENTS; PEPTIDES; PROGLUCAGON; PROTEIN PRECURSORS;

EID: 0030901415     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.59.1.257     Document Type: Review

References (114)

1. Ahrén B, Lundquist I. 1980. Effects of glicentin on insulin secretion. Horm. Metab. Res. 12:582-86
2. Baldissera FGA, Holst JJ, Knuhtsen S, Hilsted L, Nielsen OV. 1988. Oxyntomodulin (glicentin 33-69) pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs. Regul. Pept. 21:151-66
3. Bataille D, Tatemoto K, Gespach C, Jörnvall H, Rosselin G, Mutt V. 1982. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett. 146:79-86
4. Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC. 1983. Exon duplication and divergence in the human preproglucagon gene. Nature 304:368-71
5. Bell GI, Santerre RF, Mullenbach GT. 1983. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302:716-18
6. Böttcher G. 1991. Peptide YY in gut and pancreas. PhD thesis. Univ. Lund, Sweden. 56 pp.
7. Buhl T, Thim L, Kofod H, Ørskov C, Harling H, Holst JJ. 1988. Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. J. Biol. Chem. 263:8621-24
8. Carles-Bonnet C, Jarrousse C, Niel H, Martinez J, Bataille D. 1991. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat. Eur. J. Pharmacol. 203:245-52
9. Collie NL, Walsh JH, Wong HC, Shively JE, Davis MT, et al. 1994. Purification and sequence of rat oxyntomodulin. Proc. Natl. Acad. Sci. USA 91:9362-66
10. D'Alessio DA, Kahn SE, Leusner C, Ensinck JW. 1994. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J. Clin. Invest. 93:2263-66
11. D'Alessio DA, Prigeon RL, Ensinck JW. 1995. Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide-1. Diabetes 44:1433-37
12. Deacon CF, Johnsen AH, Holst JJ. 1995. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J. Clin. Endocrinol. Metab. 80:952-57
13. Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. 1995. Both subcutaneous and intravenously administered glucagon-like peptide-1 are rapidly degraded from the amino terminus in type II diabetic patients and in healthy subjects. Diabetes 44:1126-31
14. Deacon CF, Klarskov L, Olesen M, Pridal L, Holst JJ. 1996. Differential organ specific metabolism of glucagon-like peptide-1 in the anesthetized pig. Am. J. Physiol. 271:E458-64
15. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL. 1996. Induction of intestinal epithelial proliferation by glucagon-like peptide-2. Proc. Natl. Acad. Sci. USA 93:7911-16
16. Egan JM, Montrose-Rafizadeh C, Wang Y, Berrnier M, Roth J. 1994. Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3t3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action. Endocrinology 135:2070-75
17. Eissele R, Göke R, Willemer S, Harthus HP, Vermeer H, et al. 1992. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur. J. Clin. Invest. 22:283-91
18. Eissele R, Koop H, Arnold R. 1990. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in the rat. Scand. J. Gastroenterol 25:449-54
19. Fehmann H-C, Göke R, Göke B. 1995. Cell and molecular biology of the incretin hormones glucagon-like peptide-I (GLP-1) and glucose-dependent insulin releasing polypeptide (GIP). Endocr. Rev. 16:390-410
20. Fehmann H-C, Habener JF. 1992. Insulinotropic hormone glucagon-like peptide-I (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130:159-66
21. Fieseler P, Bridenbaugh S, Nustede R, Martell J, Ørskov C, et al. 1995. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-1 but not by CCK-8. Am. J. Physiol 268:E949-55
22. Göke R, Larsen PJ, Mikkelsen JD, Sheikh S. 1995. Distribution of GLP-1 binding sites in the rat brain. Evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7:2294-2300
23. Gromada J, Dissing S, Bopkvist K, Renström E, Frøkjär-Jensen J, et al. 1995. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting βTC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44:767-74
24. Gros L, Thorens B, Bataille D, Kervran A. 1993. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology 133:631-38
25. Hartmann B, Johnsen AH, Ørskov C, Holst JJ. 1996. Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2). Diabetes 45:300A (Suppl.)
26. Hartmann B, Ørskov C, Wettergren A, Holst JJ. 1995. Diurnal profiles of glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) in normal man. Diabetologia 38(Suppl. 1):A167
27. Heding LG. 1971. Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7:10-19
28. Herrmann-Rinke C, Vöge A, Hess M, Göke B. 1995. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J. Endocrinol. 147:25-31
29. Holst JJ. 1980. Evidence that glicentin contains the entire glucagon sequence. Biochem. J. 187:337-43
30. Holst JJ. 1982. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem. J. 207:381-88
31. Holst JJ. 1983. Gut glucagon, enteroglucagon, gut GLI, glicentin - current status. Gastroenterology 84:1602-13
32. Holst JJ. 1983. Radioreceptorassays for glucagon. In Glucagon: Handbook of Experimental Pharmacology, ed. PJ Lefebvre, 60/1:245-61. Berlin: Springer-Verlag
33. Holst JJ. 1988. Enteroglucagon. In Gastrointestinal Hormones. Advances in Metabolic Disorders, ed. M Mutt, 11:393-420. San Diego: Academic
34. Holst JJ. 1994. Glucagon-like peptide-I (GLP-1) - a newly discovered GI hormone. Gastroenterology 107:1848-55
35. Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, Ørskov C. 1994. Proglucagon processing in porcine and human pancreas. J. Biol. Chem. 269:18827-33
36. Holst JJ. Nauck MA, Deacon CF, Ørskov C. 1996. Potential of GLP-1 in diabetes management. In Glucagon III. Handbook of Experimental Pharmacology, ed. PJ Lefebvre, vol. 123. Berlin: Springer-Verlag. In press
37. Holst JJ, Ørskov C. 1994. Glucagon and other proglucagon-derived peptides. In Gut Peptides: Biochemistry and Physiology, ed. JH Walsh, GJ Dockray, pp. 305-40. New York: Raven
38. Holst JJ, Ørskov C, Hartmann B, Deacon CF. 1996. Posttranslational processing of proglucagon and postsecretory fate of proglucagon products. In The Insulinotropic Gut Hormone Glucagon-like Peptide-1. Frontiers in Diabetes, ed. HC Fehmann, B Göke. Basel: Karger. In press
39. Holst JJ, Ørskov AC, Schwartz TW, Nielsen OV. 1987. Truncated glucagonlike peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211:169-74
40. Holst JJ, Wettergren A, Wøjdemann M, Poulsen SS, Ørskov C. 1995. Glucagonlike peptide-1 (GLP-1): an important enterogastrone acting via the central nervous system. Hepato-Gastroenterology 42:1071
41. Holz GG, Kühtreiber WM, Habener JF. 1993. Pancreatic beta-cells are rendered glucose competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-65
42. 2+-signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J. Biol. Chem. 270:17749-59
43. Hoosein NM, Gurd RS. 1985. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett. 178:83-86
44. Hvidberg A, Toft Nielsen M, Hilsted J, Orskov C, Holst JJ. 1994. Effect of glucagon-like peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man. Metabolism 43:104-8
45. Irwin DM, Wong J. 1995. Trout and chicken proglucagon: alternative splicing generates mRNA transcripts encoding glucagon-like peptide 2. Mol. Endocrinol. 9:267-77
46. Jarrousse C, Audousset-Puech M-P, Dubrasquet M. 1985. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion. FEBS Lett. 188:81-84
47. Jarrousse C, Carles-Bonnet C, Niel H, Sabatier R, Audousset-Puech M-P, et al. 1993. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat. Am. J. Physiol. 264:G816-23
48. Jia X, Brown JC, Pederson RA, McIntosh CHS. 1995. The effects of glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 (7-36) on insulin secretion. Am. J. Physiol. 268:E645-51
49. Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK. 1988. Distribution of glucagon-like peptide I (GLP-I), glucagon, and glicentin in the rat brain: and immunocytochemical study. J. Comp. Neurol. 271:519-32
50. Kanse SM, Kreymann B, Ghatei MA, Bloom SR. 1988. Identification and characterization of glucagon-like peptide-7-36 amide binding sites in the rat brain and lung. FEBS Lett. 241:209-12
51. Kawai K, Sasaki K, Yokota C, Sato T, Yamashita K. 1995. Recombinant DNA glicentin and its biological activity. Diabetologia 38(Suppl. 1):A130
52. Kirkegaard P, Loud FB, Moody AJ, Holst JJ, Christiansen J. 1982. Glicentin inhibits gastric acid in the rat. Nature 297:156-57
53. Kolligs F, Fehmann HC, Göke R, Göke B. 1995. Reduction of the incretin effect in rats by the glucagon-like peptide-1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19
54. Kreymann B, Ghatei MA, Williams G, Bloom SR. 1987. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet II:1300-3
55. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. 1996. Distribution of glucagon-like peptide-1 (GLP-1) and other preproglucagon derived peptides in the rat hypothalamus and brain stem. Neuroscience. In press
56. Layer P, Franke A, Holst JJ, Grandt D, Goebell H. 1996. Glucagon-like peptide-1 (GLP-1) inhibits pancreatic enzyme secretion in humans. Gastroenterology 110:F1409
57. Layer P, Holst JJ. 1993. GLP-1: A humoral mediator of the ileal brake in humans? Digestion 54:385-86
58. Layer P, Holst JJ, Grandt D, Goebell H. 1995. Ileal release of glucagonlike peptide-1 (GLP-1): association with inhibition of gastric acid in humans. Dig. Dis. Sci. 40:1074-82
59. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, et al. 1996. Expression and functional activity of glucagon- GLP-1 and GIP receptors in rat pancreatic islets cells. Diabetes 45:257-61
60. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. 1986. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J. Biol. Chem. 261:11880-89
61. Mojsov S, Weir GC, Habener JF. 1987. Insulinotropin: glucagon-like peptide-I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused pancreas. J. Clin. Invest. 79:616-19
62. Moody AJ, Holst JJ, Thim L, Jensen SL. 1981. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature 289:514-16
63. Moody AJ, Thim L. 1983. Glucagon, glicentin and related peptides. In Glucagon: Handbook of Experimental Pharmacology, ed. PJ Lefebvre 66/1:139-74. Berlin: Springer-Verlag
64. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. 1993. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1 (7-36) amide infused at near-physiological insulinotropic and glucose concentrations. J. Clin. Endocrinol. Metab. 76:912-17
65. Nauck MA, Ettler R, Niedereichholz U, Orskov C, Holst JJ, Schmiegel W. 1995. Inhibition of gastric emptying by GLP-1 (7-36 amide) or (7-37): effects on postprandial glycemia and insulin secretion. Gut 37(Suppl. 2):A124 (Abstr.)
66. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. 1993. Preserved incretin activity of GLP-1 (7-36 amide) but not of synthetic human GIP in patients with type 2-diabetes mellitus. J. Clin. Invest. 91:301-7
67. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. 1993. Normalization of fasting hyperglycemia by exogenous GLP-1 in type-2 diabetic patients. Diabetologia 36:741-44
68. Novak U, Wilks A, Buell G, McEwen S. 1987. Identical mRNA for preproglucagon in pancreas and gut. Eur. J. Biochem. 164:553-58
69. Ohneda A, Ohneda K, Nagasaki T, Sasaki K. 1995. Insulinotropic action of human glicentin in dogs. Metabolism 44:47-51
70. Ørskov C. 1992.Glucagon-like peptide-1, a new hormone of the enteroinsular axis. Diabetologia 35:701-11
71. Ørskov C, Bersani M, Johnsen AH, Højrup P, Holst JJ. 1989. Complete sequences of glucagon-like peptide-1 (GLP-1) from human and pig small intestine. J. Biol. Chem. 264:12826-29
72. Ørskov C, Buhl T, Rabenhøj L, Kofod H, Holst JJ. 1989. Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine. FEBS Lett. 247:193-206
73. Ørskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV. 1986. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from the pig small intestine, but not pancreas. Endocrinology 119:1467-75
74. Ørskov C, Holst JJ, Nielsen OV. 1988. Effect of truncated glucagon-like peptide-1 (proglucagon 78-107 amide) on endocrine secretion from pig pancreas, antrum and stomach. Endocrinology 123:2009-13
75. Ørskov C, Holst JJ, Poulsen SS, Kirkegaard P. 1987. Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874-81
76. Ørskov C, Poulsen SS. 1991. Glucagon-like peptide-1 receptors only in islets of Langerhans. Autoradiographic survey of extracerebral tissues in rats. Diabetes 40:1292-96
77. Ørskov C, Poulsen SS, Møller M, Holst JJ. 1996. GLP-1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide-1. Diabetes 45:832-35
78. Ørskov C, Rabenhøj L, Kofod H, Wettergren A, Holst JJ. 1994. Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 43:535-39
79. Ørskov C, Wettergren A, Poulsen SDS, Holst JJ. 1995. Is the effect of glucagon-like peptide-1 on gastric emptying centrally mediated? Diabetologia 38(Suppl. 1):A39(Abstr.)
80. Ørskov L, Holst JJ, Ørskov C, Møller N, Schmitz O. 1996. Acute GLP-1 administration does not affect insulin sensitivity in healthy man. Diabetologia 139:1227-32
81. Patzelt C, Schiltz E. 1984. Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences. Proc. Natl. Acad. Sci. USA 81:5007-12
82. Patzelt C, Tager HS, Carroll RJ, Steiner DF. 1979. Identification and processing of proglucagon in pancreatic islets. Nature 282:260-64
83. Plaisance P, Bernhard C, Chayvialle J-A, Cuber J-C. 1994. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon. Endocrinology 135:2398-93
84. Pridal L, Ingwersen SH, Larsen FS, Holst JJ, Adelhorst K, Kirk O. 1995. Comparison of sandwich ELISA and RIA for determination of exogenous GLP-1 (7-36 amide) in plasma. J. Pharmaceut. Biomed. Anal. 13:841-50
85. Roberge JN, Brubaker PL. 1993. Regulation of proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-40
86. Rouillé Y, Martin S, Steiner DF. 1995. Differential processing by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. J. Biol. Chem. 270:26488-96
87. Rouillé Y, Westermark G, Martin SK, Steiner DF. 1994. Proglucagon is processed to glucagon by prohormone convertase PC2 in α TC1-6 cells. Proc. Natl. Acad. Sci. USA 91:3242-46
88. Schick RR, vorm Walde T, Zimmermann JP, Schusdziarra V, Classen M. 1994. Glucagon-like peptide 1 - a novel brain peptide involved in feeding regulation. In Obesity in Europe, ed. H Ditschuneit, FA Gries, H Hauner, V Schusdziarra, JG Wechsler, pp. 363-67. London: Libbey
89. Schjoldager BTG, Mortensen PE, Christiansen J, Orskov C, Holst JJ. 1989. GLP-1 (glucagon-like peptide-1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in man. Dig. Dis. Sci. 35:703-8
90. Schjoldager BTG, Mortensen PE, Myhre J, Christiansen J, Holst JJ. 1989. Oxyntomodulin from the distal gut: role in the regulation of gastric and pancreatic functions. Dig. Dis. Sci. 34:1411-19
91. Schmidtler J, Schepp W, Janczewska I, Weigert Fürlinger C, Schusdziarra V, Classen M. 1991. GLP-1-(7-36) amide, - (1-37), and -(1-36) amide: potent cAMP-dependent stimuli of rat parietal cell function. Am. J. Physiol. 260:G940-50
92. Sheikh SP, Baldissera FGA, Karlsen FØ, Holst JJ. 1985. Glicentin is present in the pig pancreas. FEBS Lett. 179:1-6
93. Shimizu I, Hirota M, Obhoshi C, Shima K. 1987. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology 121:1076-82
94. Sugiyama K, Manaka H, Kato T, Yamatani K, Tominaga M, Sasaki H. 1994. Stimulation of truncated glucagon like peptide-1 secretion from isolated perfused canine ileum by glucose absorption. Digestion 55:24-28
95. Tang-Christensen M, Larsen PJ, Göke R, Fink-Jensen A, Jessop DS, et al. 1996. Brain GLP-1 (7-36) amide receptors play a major role in regulation of food and water intake. Am. J. Physiol. 271 :In press
96. Thim L, Moody AJ. 1981. The primary structure of glicentin (proglucagon). Regul. Pept. 2:139-51
97. Thim L, Moody AJ. 1982. Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas. Biochim. Biophys. Acta 703:134-41
98. Thorens B. 1992. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. USA 89: 8641-45
99. Toft-Nielsen M, Madsbad S, Holst JJ. 1996. The effect of GLP-1 on glucose elimination. Diabetes 45:552-56
100. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, et al. 1996. A role for glucagon-like peptide-1 in the regulation of feeding. Nature 379:69-72
101. Unger RH, Eisentraut AM, Sims K, McCall MS, Madison LL. 1961. Sites of origin of glucagon in dogs and humans. Clin. Res. 9:53
102. Unger RH, Ohneda A, Valverde I, Eisentraut AM, Exton J. 1968. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J. Clin. Invent. 47:48-65
103. Uttenthal LO, Toledano A, Blazquez E. 1992. Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain. Neuropeptides 21:143-46
104. Valverde I, Morales M, Clemente F, Lopez-Delgado MI, Delgado E, et al. 1994. Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett. 349:313-16
105. Varndell IM, Bishop A, Sikri E, Uttenthal LO, Bloom SR, Polak JM. 1985. Localization of glucagon-like peptide GLP immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J. Histochem. Cytochem. 33:1080-90
106. Villanueva-Penacarrillo ML. Alcanatara AI, Clemente F, Delgado E, Valverde I. 1994. Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle. Diabetologia 37:1163-66
107. Walsh JH. 1994. Gastrointestinal hormones. In Physiology of the Gastrointestinal Tract, ed. LR Johnson, pp. 1-128. New York: Raven. 3rd ed.
108. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei M, Bloom SR. 1995. Glucagon-like peptide-1 is a physiological incretin in rat. J. Clin. Invest. 95:417-21
109. Wei Y, Mojsov S. 1995. Tissue-specific expression of the human receptor for glucagon-like peptide-1: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 358:219-24
110. Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ. 1994. Glucagon-like peptide-1 (GLP-1) 7-36 amide and peptide YY from the L-cell in the ileal mucosa are potent inhibitors of vagally induced gastric acid in man. Scand. J. Gastroenterol. 29:501-5
111. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. 1993. Truncated GLP-1 (proglucagon 72-107 amide) inhibits gastric and pancreatic functions in man. Dig. Dis. Sci. 38:665-73
112. White JW, Saunders GF. 1986. Structure of the human glucagon gene. Nucleic Acids Res. 14:4719-30
113. Yamada T, Solomon TE, Petersen H. 1980. Effects of gastrointestinal polypeptides on hormone content of the endocrine pancreas in the rat. Am. J. Physiol. 238:G525-30
114. Yanaihara C, Matsumoto T, Kadowaki M, Iguchi K, Yanaihara N. 1985. Rat pancreas contains the proglucagon (64-69) fragment and arginine stimulates its release. FEBS Lett. 187:307-10